DexCom Gross Profit 2010-2024 | DXCM - Macrotrends

DexCom gross profit for the quarter ending September 30, 2024 was $0.594B, a 4.73% decline year-over-year. DexCom gross profit for the twelve months ending September 30, 2024 was …

CouponFollow Extension

73%
OFF

DexCom Gross Profit 2010-2024 | DXCM - Macrotrends

1 week from now

DexCom gross profit for the quarter ending September 30, 2024 was $0.594B, a 4.73% decline year-over-year. DexCom gross profit for the twelve months ending September 30, 2024 was …

macrotrends.net

24%
OFF

DexCom EPS - Earnings Per Share 2010-2024 | DXCM | MacroTrends

1 week from now

Sep 30, 2024 · DexCom EPS for the quarter ending September 30, 2024 was $0.34, a 17.24% increase year-over-year.; DexCom 2023 annual EPS was $1.3, a 58.54% increase from 2022.; …

macrotrends.net

$3.95
OFF

DexCom, Inc. (DXCM) Statistics & Valuation Metrics - Stock Analysis

1 week from now

Oct 24, 2024 · Income Statement. In the last 12 months, DexCom had revenue of $3.95 billion and earned $680.80 million in profits. Earnings per share was $1.67. Revenue. 3.95B. Gross …

stockanalysis.com

24%
OFF

Dexcom Reports First Quarter 2024 Financial Results

1 week from now

Mar 31, 2024 · DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% …

dexcom.com

49%
OFF

DexCom Revenue 2010-2024 | DXCM - Macrotrends

1 week from now

DexCom annual revenue for 2023 was $3.622B, a 24.49% increase from 2022. DexCom annual revenue for 2022 was $2.91B, a 18.84% increase from 2021. DexCom annual revenue for …

macrotrends.net

97%
OFF

DexCom Revenue 2014-2024 - Stock Analysis

1 week from now

4 days ago · DexCom had revenue of $994.20M in the quarter ending September 30, 2024, with 1.97% growth. This brings the company's revenue in the last twelve months to $3.95B, up …

stockanalysis.com

58%
OFF

DexCom Net Income 2010-2024 | DXCM | MacroTrends

1 week from now

DexCom net income for the twelve months ending September 30, 2024 was $0.681B, a 80.58% increase year-over-year. DexCom annual net income for 2023 was $0.542B, a 58.7% increase …

macrotrends.net

9%
OFF

DexCom Revenue 2010-2023 | DXCM | MacroTrends

1 week from now

DexCom revenue for the quarter ending December 31, 2023 was $1.035B , a 26.9% increase year-over-year. DexCom revenue for the twelve months ending December 31, 2023 was …

macrotrends.net

FAQs about DexCom Gross Profit 2010-2024 | DXCM - Macrotrends Coupon?

What is Dexcom revenue?

Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. DexCom revenue for the quarter ending March 31, 2023 was $0.742B, a 17.92% increase year-over-year. DexCom revenue for the twelve months ending March 31, 2023 was $3.023B, a 17.5% increase year-over-year. ...

Is Dexcom reiterating guidance for fiscal year 2024?

Dexcom is updating fiscal year 2024 guidance for Revenue, and reiterating guidance for Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin, and Adjusted EBITDA Margin at the following levels: First Quarter 2024 Financial Results ...

How much money does Dexcom make a year?

In the last 12 months, DexCom had revenue of $3.80 billion and earned $639.30 million in profits. Earnings per share was $1.54. The company has $2.90 billion in cash and $2.53 billion in debt, giving a net cash position of $364.50 million or $0.92 per share. ...

When will Dexcom report its financial results?

Dexcom will report its audited full fourth quarter and fiscal 2023 financial results on Thursday, February 8, 2024 after the close of market. Management is currently scheduled to host a conference call at 4:30 p.m. (Eastern Time) that day. More details will be provided later. About DexCom, Inc. ...

What is Dexcom's 2024 organic growth expectation?

Dexcom's 2024 organic growth expectation excludes approximately $30 million of fiscal year 2023 revenue related to the divestiture of certain non-CGM assets. Conference Call Management will hold a conference call today starting at 4:30 p.m. (Eastern Time). The conference call will be concurrently webcast. ...

What did Dexcom do in the first quarter 2024?

First Quarter 2024 Strategic Highlights: Received FDA clearance for Stelo, Dexcom’s new CGM system designed for people with type 2 diabetes who are not on insulin therapy, as the first glucose biosensor in the U.S. cleared for use without a prescription. ...